TriSalus Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Sep 24 | BuyUS$75,359 | Mary Szela | Individual | 14,815 | US$5.20 | |
10 Sep 24 | BuyUS$24,850 | Mary Szela | Individual | 5,000 | US$4.97 | |
28 Aug 24 | SellUS$50 | George Martin | Individual | 9 | US$5.50 |
Insider Trading Volume
Insider Buying: TLSI insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,972,299 | 6.47% |
Individual Insiders | 6,708,325 | 22% |
General Public | 10,631,511 | 34.9% |
Institutions | 11,178,937 | 36.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,167,756 | US$27.3m | 0% | 100.0% | |||
1,546,569 | US$6.9m | 0% | no data | |||
1,390,474 | US$6.2m | 0% | no data | |||
1,387,588 | US$6.1m | 80.2% | 9.35% | |||
1,370,028 | US$6.1m | 0% | no data | |||
1,254,259 | US$5.6m | 0% | no data | |||
931,903 | US$4.1m | 0% | no data | |||
643,740 | US$2.9m | 0% | 0.07% | |||
573,690 | US$2.5m | 0% | no data | |||
525,267 | US$2.3m | 0% | no data | |||
521,539 | US$2.3m | 0% | no data | |||
514,589 | US$2.3m | 0% | no data | |||
426,921 | US$1.9m | 0% | 0.06% | |||
416,138 | US$1.8m | 0% | no data | |||
322,737 | US$1.4m | 0% | no data | |||
277,127 | US$1.2m | 36.4% | no data | |||
263,004 | US$1.2m | 8.15% | no data | |||
247,176 | US$1.1m | 0% | no data | |||
200,427 | US$887.9k | 45.4% | no data | |||
102,993 | US$456.3k | 0% | no data | |||
97,888 | US$433.6k | -20.4% | no data | |||
94,754 | US$419.8k | 0% | no data | |||
81,845 | US$362.6k | 0% | 100.0% | |||
67,817 | US$300.4k | 0% | no data | |||
39,999 | US$177.2k | 0% | 0.09% |